Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 323 entries
Sorted by: Best Match Show Resources per page
Quality of Life in Patients with Substance Use Disorders Admitted to Detoxification Compared with Those Admitted to Hospitals for Medical Disorders: Follow-Up Results.

Substance abuse : research and treatment

Vederhus JK, Pripp AH, Clausen T.
PMID: 27226719
Subst Abuse. 2016 May 18;10:31-7. doi: 10.4137/SART.S39192. eCollection 2016.

Quality of life (QoL) in patients admitted to a general hospital was compared with those admitted to a detoxification unit for the treatment of substance use disorder (SUD). This study combines data from two separate data collections: a cross-sectional...

Cite
Vederhus JK, Pripp AH, Clausen T. Quality of Life in Patients with Substance Use Disorders Admitted to Detoxification Compared with Those Admitted to Hospitals for Medical Disorders: Follow-Up Results. Subst Abuse. 2016;10:31-7doi: 10.4137/SART.S39192.
Vederhus, J. K., Pripp, A. H., & Clausen, T. (2016). Quality of Life in Patients with Substance Use Disorders Admitted to Detoxification Compared with Those Admitted to Hospitals for Medical Disorders: Follow-Up Results. Substance abuse : research and treatment, 1031-7. https://doi.org/10.4137/SART.S39192
Vederhus, John-Kåre, et al. "Quality of Life in Patients with Substance Use Disorders Admitted to Detoxification Compared with Those Admitted to Hospitals for Medical Disorders: Follow-Up Results." Substance abuse : research and treatment vol. 10 (2016): 31-7. doi: https://doi.org/10.4137/SART.S39192
Vederhus JK, Pripp AH, Clausen T. Quality of Life in Patients with Substance Use Disorders Admitted to Detoxification Compared with Those Admitted to Hospitals for Medical Disorders: Follow-Up Results. Subst Abuse. 2016 May 18;10:31-7. doi: 10.4137/SART.S39192. eCollection 2016. PMID: 27226719; PMCID: PMC4874746.
Copy Download .nbib Format: NLM
Heterogeneous regulation of bacterial natural product biosynthesis via a novel transcription factor.

Heliyon

Heinrich AK, Glaeser A, Tobias NJ, Heermann R, Bode HB.
PMID: 27957552
Heliyon. 2016 Nov 29;2(11):e00197. doi: 10.1016/j.heliyon.2016.e00197. eCollection 2016 Nov.

Biological diversity arises among genetically equal subpopulations in the same environment, a phenomenon called phenotypic heterogeneity. The life cycle of the enteric bacterium

Cite
Heinrich AK, Glaeser A, Tobias NJ, et al. Heterogeneous regulation of bacterial natural product biosynthesis via a novel transcription factor. Heliyon. 2016;2(11):e00197doi: 10.1016/j.heliyon.2016.e00197.
Heinrich, A. K., Glaeser, A., Tobias, N. J., Heermann, R., & Bode, H. B. (2016). Heterogeneous regulation of bacterial natural product biosynthesis via a novel transcription factor. Heliyon, 2(11), e00197. https://doi.org/10.1016/j.heliyon.2016.e00197
Heinrich, Antje K, et al. "Heterogeneous regulation of bacterial natural product biosynthesis via a novel transcription factor." Heliyon vol. 2,11 (2016): e00197. doi: https://doi.org/10.1016/j.heliyon.2016.e00197
Heinrich AK, Glaeser A, Tobias NJ, Heermann R, Bode HB. Heterogeneous regulation of bacterial natural product biosynthesis via a novel transcription factor. Heliyon. 2016 Nov 29;2(11):e00197. doi: 10.1016/j.heliyon.2016.e00197. eCollection 2016 Nov. PMID: 27957552; PMCID: PMC5133734.
Copy Download .nbib Format: NLM
A Machine Learning Approach to Evaluating Illness-Induced Religious Struggle.

Biomedical informatics insights

Glauser J, Connolly B, Nash P, Grossoehme DH.
PMID: 28469429
Biomed Inform Insights. 2017 Feb 08;9:1178222616686067. doi: 10.1177/1178222616686067. eCollection 2017.

Religious or spiritual struggles are clinically important to health care chaplains because they are related to poorer health outcomes, involving both mental and physical health problems. Identifying persons experiencing religious struggle poses a challenge for chaplains. One potentially underappreciated...

Cite
Glauser J, Connolly B, Nash P, et al. A Machine Learning Approach to Evaluating Illness-Induced Religious Struggle. Biomed Inform Insights. 2017;9:1178222616686067doi: 10.1177/1178222616686067.
Glauser, J., Connolly, B., Nash, P., & Grossoehme, D. H. (2017). A Machine Learning Approach to Evaluating Illness-Induced Religious Struggle. Biomedical informatics insights, 91178222616686067. https://doi.org/10.1177/1178222616686067
Glauser, Joshua, et al. "A Machine Learning Approach to Evaluating Illness-Induced Religious Struggle." Biomedical informatics insights vol. 9 (2017): 1178222616686067. doi: https://doi.org/10.1177/1178222616686067
Glauser J, Connolly B, Nash P, Grossoehme DH. A Machine Learning Approach to Evaluating Illness-Induced Religious Struggle. Biomed Inform Insights. 2017 Feb 08;9:1178222616686067. doi: 10.1177/1178222616686067. eCollection 2017. PMID: 28469429; PMCID: PMC5391196.
Copy Download .nbib Format: NLM
Targeted Nanotechnology in Glioblastoma Multiforme.

Frontiers in pharmacology

Glaser T, Han I, Wu L, Zeng X.
PMID: 28408882
Front Pharmacol. 2017 Mar 31;8:166. doi: 10.3389/fphar.2017.00166. eCollection 2017.

Gliomas, and in particular glioblastoma multiforme, are aggressive brain tumors characterized by a poor prognosis and high rates of recurrence. Current treatment strategies are based on open surgery, chemotherapy (temozolomide) and radiotherapy. However, none of these treatments, alone or...

Cite
Glaser T, Han I, Wu L, et al. Targeted Nanotechnology in Glioblastoma Multiforme. Front Pharmacol. 2017;8:166doi: 10.3389/fphar.2017.00166.
Glaser, T., Han, I., Wu, L., & Zeng, X. (2017). Targeted Nanotechnology in Glioblastoma Multiforme. Frontiers in pharmacology, 8166. https://doi.org/10.3389/fphar.2017.00166
Glaser, Talita, et al. "Targeted Nanotechnology in Glioblastoma Multiforme." Frontiers in pharmacology vol. 8 (2017): 166. doi: https://doi.org/10.3389/fphar.2017.00166
Glaser T, Han I, Wu L, Zeng X. Targeted Nanotechnology in Glioblastoma Multiforme. Front Pharmacol. 2017 Mar 31;8:166. doi: 10.3389/fphar.2017.00166. eCollection 2017. PMID: 28408882; PMCID: PMC5374154.
Copy Download .nbib Format: NLM
Exchange Coupling in an Isostructural Series of Face-Sharing Bioctahedral Complexes [LM(II)(&mgr;-X)(3)M(II)L]BPh(4) (M = Mn, Fe, Co, Ni, Zn; X = Cl, Br; L = 1,4,7-Trimethyl-1,4,7-triazacyclononane).

Inorganic chemistry

Bossek U, Nühlen D, Bill E, Glaser T, Krebs C, Weyhermüller T, Wieghardt K, Lengen M, Trautwein AX.
PMID: 11669919
Inorg Chem. 1997 Jun 18;36(13):2834-2843. doi: 10.1021/ic970119h.

The reaction of the divalent metal halides ZnCl(2), ZnBr(2), MnCl(2).4CH(3)CN, MnBr(2), FeCl(2).4CH(3)CN, CoCl(2).4CH(3)CN, CoBr(2), NiCl(2).6H(2)O, and NiBr(2), respectively, with the macrocycle 1,4,7-trimethyl-1,4,7-triazacyclononane (L) (1:1) in anhydrous acetonitrile, acetone, chloroform, or ethanol affords upon additon of NaBPh(4) the isomorphous series...

Cite
Bossek U, Nühlen D, Bill E, et al. Exchange Coupling in an Isostructural Series of Face-Sharing Bioctahedral Complexes [LM(II)(&mgr;-X)(3)M(II)L]BPh(4) (M = Mn, Fe, Co, Ni, Zn; X = Cl, Br; L = 1,4,7-Trimethyl-1,4,7-triazacyclononane). Inorg Chem. 1997;36(13):2834-2843doi: 10.1021/ic970119h.
Bossek, U., Nühlen, D., Bill, E., Glaser, T., Krebs, C., Weyhermüller, T., Wieghardt, K., Lengen, M., & Trautwein, A. X. (1997). Exchange Coupling in an Isostructural Series of Face-Sharing Bioctahedral Complexes [LM(II)(&mgr;-X)(3)M(II)L]BPh(4) (M = Mn, Fe, Co, Ni, Zn; X = Cl, Br; L = 1,4,7-Trimethyl-1,4,7-triazacyclononane). Inorganic chemistry, 36(13), 2834-2843. https://doi.org/10.1021/ic970119h
Bossek, Ursula, et al. "Exchange Coupling in an Isostructural Series of Face-Sharing Bioctahedral Complexes [LM(II)(&mgr;-X)(3)M(II)L]BPh(4) (M = Mn, Fe, Co, Ni, Zn; X = Cl, Br; L = 1,4,7-Trimethyl-1,4,7-triazacyclononane)." Inorganic chemistry vol. 36,13 (1997): 2834-2843. doi: https://doi.org/10.1021/ic970119h
Bossek U, Nühlen D, Bill E, Glaser T, Krebs C, Weyhermüller T, Wieghardt K, Lengen M, Trautwein AX. Exchange Coupling in an Isostructural Series of Face-Sharing Bioctahedral Complexes [LM(II)(&mgr;-X)(3)M(II)L]BPh(4) (M = Mn, Fe, Co, Ni, Zn; X = Cl, Br; L = 1,4,7-Trimethyl-1,4,7-triazacyclononane). Inorg Chem. 1997 Jun 18;36(13):2834-2843. doi: 10.1021/ic970119h. PMID: 11669919.
Copy Download .nbib Format: NLM
[Comparative Efficacy of Flupentixol and Risperidone on Schizophrenic Negative Symptoms].

Psychiatrische Praxis

Philipp M, Lesch OM, Schmauss M, Dose M, Glaser T.
PMID: 13130348
Psychiatr Prax. 2003 May;30:94-96. doi: 10.1055/s-2003-39746.

The efficacy of flupentixol and risperidone were compared in a randomized double-blind study in 153 chronic schizophrenic patients. Flupentixol showed to be not inferior to risperidone concerning schizophrenic negative symptoms at week 8, 16 and 24. Positive symptoms and...

Cite
Philipp M, Lesch OM, Schmauss M, et al. Vergleichbare Wirksamkeit von Flupentixol und Risperidon auf schizophrene Negativsymptomatik. [Comparative Efficacy of Flupentixol and Risperidone on Schizophrenic Negative Symptoms]. Psychiatr Prax. 2003;30:94-96doi: 10.1055/s-2003-39746.
Philipp, M., Lesch, O. M., Schmauss, M., Dose, M., & Glaser, T. (2003). Vergleichbare Wirksamkeit von Flupentixol und Risperidon auf schizophrene Negativsymptomatik. [Comparative Efficacy of Flupentixol and Risperidone on Schizophrenic Negative Symptoms]. Psychiatrische Praxis, 3094-96. https://doi.org/10.1055/s-2003-39746
Philipp, Michael, et al. "Vergleichbare Wirksamkeit von Flupentixol und Risperidon auf schizophrene Negativsymptomatik." [Comparative Efficacy of Flupentixol and Risperidone on Schizophrenic Negative Symptoms]. Psychiatrische Praxis vol. 30 (2003): 94-96. doi: https://doi.org/10.1055/s-2003-39746
Philipp M, Lesch OM, Schmauss M, Dose M, Glaser T. Vergleichbare Wirksamkeit von Flupentixol und Risperidon auf schizophrene Negativsymptomatik. [Comparative Efficacy of Flupentixol and Risperidone on Schizophrenic Negative Symptoms]. Psychiatr Prax. 2003 May;30:94-96. doi: 10.1055/s-2003-39746. German. PMID: 13130348.
Copy Download .nbib Format: NLM
Electronic structure of linear thiophenolate-bridged heteronuclear complexes [LFeMFeL](n)(+) (M = Cr, Co, Fe; n = 1-3): a combination of kinetic exchange interaction and electron delocalization.

Journal of the American Chemical Society

Chibotaru LF, Girerd JJ, Blondin G, Glaser T, Wieghardt K.
PMID: 14531706
J Am Chem Soc. 2003 Oct 15;125(41):12615-30. doi: 10.1021/ja030027t.

The electronic properties of the isostructural series of heterotrinuclear thiophenolate-bridged complexes of the general formula [LFeMFeL](n)(+) with M = Cr, Co and Fe where L represents the trianionic form of the ligand 1,4,7-tris(4-tertbutyl-2-mercaptobenzyl)-1,4,7-triazacyclononane, synthesized and investigated by a number...

Cite
Chibotaru LF, Girerd JJ, Blondin G, et al. Electronic structure of linear thiophenolate-bridged heteronuclear complexes [LFeMFeL](n)(+) (M = Cr, Co, Fe; n = 1-3): a combination of kinetic exchange interaction and electron delocalization. J Am Chem Soc. 2003;125(41):12615-30doi: 10.1021/ja030027t.
Chibotaru, L. F., Girerd, J. J., Blondin, G., Glaser, T., & Wieghardt, K. (2003). Electronic structure of linear thiophenolate-bridged heteronuclear complexes [LFeMFeL](n)(+) (M = Cr, Co, Fe; n = 1-3): a combination of kinetic exchange interaction and electron delocalization. Journal of the American Chemical Society, 125(41), 12615-30. https://doi.org/10.1021/ja030027t
Chibotaru, Liviu F, et al. "Electronic structure of linear thiophenolate-bridged heteronuclear complexes [LFeMFeL](n)(+) (M = Cr, Co, Fe; n = 1-3): a combination of kinetic exchange interaction and electron delocalization." Journal of the American Chemical Society vol. 125,41 (2003): 12615-30. doi: https://doi.org/10.1021/ja030027t
Chibotaru LF, Girerd JJ, Blondin G, Glaser T, Wieghardt K. Electronic structure of linear thiophenolate-bridged heteronuclear complexes [LFeMFeL](n)(+) (M = Cr, Co, Fe; n = 1-3): a combination of kinetic exchange interaction and electron delocalization. J Am Chem Soc. 2003 Oct 15;125(41):12615-30. doi: 10.1021/ja030027t. PMID: 14531706.
Copy Download .nbib Format: NLM
Extending the {(Mo)MO5}12M30 capsule keplerate sequence: a {Cr30} cluster of S=3/2 metal centers with a {Na(H2O)12} encapsulate.

Angewandte Chemie (International ed. in English)

Todea AM, Merca A, Bögge H, van Slageren J, Dressel M, Engelhardt L, Luban M, Glaser T, Henry M, Müller A.
PMID: 17628480
Angew Chem Int Ed Engl. 2007;46(32):6106-10. doi: 10.1002/anie.200700795.

No abstract available.

Cite
Todea AM, Merca A, Bögge H, et al. Extending the {(Mo)MO5}12M30 capsule keplerate sequence: a {Cr30} cluster of S=3/2 metal centers with a {Na(H2O)12} encapsulate. Angew Chem Int Ed Engl. 2007;46(32):6106-10doi: 10.1002/anie.200700795.
Todea, A. M., Merca, A., Bögge, H., van Slageren, J., Dressel, M., Engelhardt, L., Luban, M., Glaser, T., Henry, M., & Müller, A. (2007). Extending the {(Mo)MO5}12M30 capsule keplerate sequence: a {Cr30} cluster of S=3/2 metal centers with a {Na(H2O)12} encapsulate. Angewandte Chemie (International ed. in English), 46(32), 6106-10. https://doi.org/10.1002/anie.200700795
Todea, Ana Maria, et al. "Extending the {(Mo)MO5}12M30 capsule keplerate sequence: a {Cr30} cluster of S=3/2 metal centers with a {Na(H2O)12} encapsulate." Angewandte Chemie (International ed. in English) vol. 46,32 (2007): 6106-10. doi: https://doi.org/10.1002/anie.200700795
Todea AM, Merca A, Bögge H, van Slageren J, Dressel M, Engelhardt L, Luban M, Glaser T, Henry M, Müller A. Extending the {(Mo)MO5}12M30 capsule keplerate sequence: a {Cr30} cluster of S=3/2 metal centers with a {Na(H2O)12} encapsulate. Angew Chem Int Ed Engl. 2007;46(32):6106-10. doi: 10.1002/anie.200700795. PMID: 17628480.
Copy Download .nbib Format: NLM
Multiple K-edge XAS for the structural analysis of thiophenolate bridged heterotrinuclear complexes.

Journal of synchrotron radiation

Meyer-Klaucke W, Glaser T, Fröba M, Tiemann M, Wong J, Trautwein AX.
PMID: 15263321
J Synchrotron Radiat. 1999 May 01;6:397-9. doi: 10.1107/S0909049598017804. Epub 1999 May 01.

No abstract available.

Cite
Meyer-Klaucke W, Glaser T, Fröba M, et al. Multiple K-edge XAS for the structural analysis of thiophenolate bridged heterotrinuclear complexes. J Synchrotron Radiat. 1999;6:397-9doi: 10.1107/S0909049598017804.
Meyer-Klaucke, W., Glaser, T., Fröba, M., Tiemann, M., Wong, J., & Trautwein, A. X. (1999). Multiple K-edge XAS for the structural analysis of thiophenolate bridged heterotrinuclear complexes. Journal of synchrotron radiation, 6397-9. https://doi.org/10.1107/S0909049598017804
Meyer-Klaucke, W, et al. "Multiple K-edge XAS for the structural analysis of thiophenolate bridged heterotrinuclear complexes." Journal of synchrotron radiation vol. 6 (1999): 397-9. doi: https://doi.org/10.1107/S0909049598017804
Meyer-Klaucke W, Glaser T, Fröba M, Tiemann M, Wong J, Trautwein AX. Multiple K-edge XAS for the structural analysis of thiophenolate bridged heterotrinuclear complexes. J Synchrotron Radiat. 1999 May 01;6:397-9. doi: 10.1107/S0909049598017804. Epub 1999 May 01. PMID: 15263321.
Copy Download .nbib Format: NLM
Alignment of Ge nanoislands on Si(111) by Ga-induced substrate self-patterning.

Physical review letters

Schmidt T, Flege JI, Gangopadhyay S, Clausen T, Locatelli A, Heun S, Falta J.
PMID: 17358960
Phys Rev Lett. 2007 Feb 09;98(6):066104. doi: 10.1103/PhysRevLett.98.066104. Epub 2007 Feb 09.

A novel mechanism is described which enables the selective formation of three-dimensional Ge islands. Submonolayer adsorption of Ga on Si(111) at high temperature leads to a self-organized two-dimensional pattern formation by separation of the 7 x 7 substrate and...

Cite
Schmidt T, Flege JI, Gangopadhyay S, et al. Alignment of Ge nanoislands on Si(111) by Ga-induced substrate self-patterning. Phys Rev Lett. 2007;98(6):066104doi: 10.1103/PhysRevLett.98.066104.
Schmidt, T., Flege, J. I., Gangopadhyay, S., Clausen, T., Locatelli, A., Heun, S., & Falta, J. (2007). Alignment of Ge nanoislands on Si(111) by Ga-induced substrate self-patterning. Physical review letters, 98(6), 066104. https://doi.org/10.1103/PhysRevLett.98.066104
Schmidt, Th, et al. "Alignment of Ge nanoislands on Si(111) by Ga-induced substrate self-patterning." Physical review letters vol. 98,6 (2007): 066104. doi: https://doi.org/10.1103/PhysRevLett.98.066104
Schmidt T, Flege JI, Gangopadhyay S, Clausen T, Locatelli A, Heun S, Falta J. Alignment of Ge nanoislands on Si(111) by Ga-induced substrate self-patterning. Phys Rev Lett. 2007 Feb 09;98(6):066104. doi: 10.1103/PhysRevLett.98.066104. Epub 2007 Feb 09. PMID: 17358960.
Copy Download .nbib Format: NLM
Targeted ferromagnetic coupling in a trinuclear copperII complex: analysis of the St = 3/2 spin ground state.

Inorganic chemistry

Glaser T, Heidemeier M, Grimme S, Bill E.
PMID: 15310193
Inorg Chem. 2004 Aug 23;43(17):5192-4. doi: 10.1021/ic049252h.

The trinuclear Cu(II) complex [(talen)Cu(II)(3)] (1) using the new triplesalen ligand H(6)talen has been synthesized and structurally characterized. The three Cu(II) ions are bridged in a m-phenylene linkage by the phloroglucinol backbone of the ligand. This m-phenylene bridging mode...

Cite
Glaser T, Heidemeier M, Grimme S, et al. Targeted ferromagnetic coupling in a trinuclear copperII complex: analysis of the St = 3/2 spin ground state. Inorg Chem. 2004;43(17):5192-4doi: 10.1021/ic049252h.
Glaser, T., Heidemeier, M., Grimme, S., & Bill, E. (2004). Targeted ferromagnetic coupling in a trinuclear copperII complex: analysis of the St = 3/2 spin ground state. Inorganic chemistry, 43(17), 5192-4. https://doi.org/10.1021/ic049252h
Glaser, Thorsten, et al. "Targeted ferromagnetic coupling in a trinuclear copperII complex: analysis of the St = 3/2 spin ground state." Inorganic chemistry vol. 43,17 (2004): 5192-4. doi: https://doi.org/10.1021/ic049252h
Glaser T, Heidemeier M, Grimme S, Bill E. Targeted ferromagnetic coupling in a trinuclear copperII complex: analysis of the St = 3/2 spin ground state. Inorg Chem. 2004 Aug 23;43(17):5192-4. doi: 10.1021/ic049252h. PMID: 15310193.
Copy Download .nbib Format: NLM
Personalizing Drug Selection Using Advanced Clinical Decision Support.

Biomedical informatics insights

Pestian J, Spencer M, Matykiewicz P, Zhang K, Vinks AA, Glauser T.
PMID: 19898682
Biomed Inform Insights. 2009 Jun 23;2:19-29. doi: 10.4137/bii.s2506.

This article describes the process of developing an advanced pharmacogenetics clinical decision support at one of the United States' leading pediatric academic medical centers. This system, called CHRISTINE, combines clinical and genetic data to identify the optimal drug therapy...

Cite
Pestian J, Spencer M, Matykiewicz P, et al. Personalizing Drug Selection Using Advanced Clinical Decision Support. Biomed Inform Insights. 2009;2:19-29doi: 10.4137/bii.s2506.
Pestian, J., Spencer, M., Matykiewicz, P., Zhang, K., Vinks, A. A., & Glauser, T. (2009). Personalizing Drug Selection Using Advanced Clinical Decision Support. Biomedical informatics insights, 219-29. https://doi.org/10.4137/bii.s2506
Pestian, John, et al. "Personalizing Drug Selection Using Advanced Clinical Decision Support." Biomedical informatics insights vol. 2 (2009): 19-29. doi: https://doi.org/10.4137/bii.s2506
Pestian J, Spencer M, Matykiewicz P, Zhang K, Vinks AA, Glauser T. Personalizing Drug Selection Using Advanced Clinical Decision Support. Biomed Inform Insights. 2009 Jun 23;2:19-29. doi: 10.4137/bii.s2506. PMID: 19898682; PMCID: PMC2773552.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 323 entries